The nation of Zimbabwe has rejected a major US healthcare agreement worth $367m (272 million pounds) over five years over the United States' request for sensitive data.
This move became public following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson later stated that the United States was requesting biological samples for research and commercial gain but was not willing to share the resulting advantages from any future vaccines.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
According to statements, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our people if a future health crisis emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already set up via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent co-operation might be designed in a way that respects the sovereignty and interests of each country."
Health Experts Response
A leading public health body expressed it recognised the official position, but suggested that negotiations must proceed considering a large portion of the nation's HIV programmes were funded by external financing.
"If specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the ongoing debate between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.